Good Health Can’t Wait.

Good Health Can’t Wait.
Dr. Reddy’s Laboratories Limited
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in Indian Rupees millions, except share data and where otherwise stated)
2.32: EMPLOYEE STOCK OPTION SCHEME (CONTINUED)
The date of grant, number of options granted, exercise price fixed by the Committee for respective options and the market price of the shares of the
Company on the day prior to the date of grant is given below:
DATE OF GRANT NUMBER OF OPTIONS GRANTED EXERCISE PRICE `
MARKET PRICE `
(AS PER SEBI GUIDELINES)
25 May 2014 40,096 5.00 2,308.70
15 June 2014 4,700 5.00 2,445.15
14 July 2014 1,000 5.00 2,700.70
Stock option activity under the DRL 2007 Plan was as follows:
CATEGORY B – PAR VALUE OPTIONS YEAR ENDED 31 MARCH 2015
PARTICULARS
SHARES ARISING
OUT OF OPTIONS
RANGE OF
EXERCISE PRICES
WEIGHTED-AVERAGE
EXERCISE PRICE
WEIGHTED- AVERAGE
REMAINING CONTRACTUAL
LIFE (MONTHS)
Outstanding at the beginning of the year 97,463 ` 5.00 ` 5.00 79
Granted during the year 45,796 5.00 5.00 90
Expired / Forfeited during the year (10,515) 5.00 5.00 -
Exercised during the year (34,394) 5.00 5.00 -
Outstanding at the end of the year 98,350 ` 5.00 ` 5.00 72
Exercisable at the end of the year 6,730 ` 5.00 ` 5.00 42
CATEGORY B – PAR VALUE OPTIONS YEAR ENDED 31 MARCH 2014
PARTICULARS
SHARES ARISING
OUT OF OPTIONS
RANGE OF
EXERCISE PRICES
WEIGHTED-AVERAGE
EXERCISE PRICE
WEIGHTED- AVERAGE
REMAINING CONTRACTUAL
LIFE (MONTHS)
Outstanding at the beginning of the year 98,608 ` 5.00 ` 5.00 73
Granted during the year 44,240 5.00 5.00 90
Expired / Forfeited during the year (14,132) 5.00 5.00 -
Exercised during the year (31,253) 5.00 5.00 -
Outstanding at the end of the year 97,463 ` 5.00 ` 5.00 79
Exercisable at the end of the year 7,265 ` 5.00 ` 5.00 44
The Company has not granted any options under Category A of “the DRL 2007 Plan”.
The Company has followed intrinsic method of accounting based on which a compensation expense of `519 (previous year: `468) has been recognized
in the statement of profit and loss.
2.33: OPERATING LEASE
The Company has leased offices and vehicles under various operating lease agreements that are renewable on a periodic basis at the option of both the
lessor and the lessee. Total expense recognised in statement of profit and loss on account of operating leases during the year amounts to ` 822 (previous
year: ` 749).
The schedule of future minimum rental payments in respect of non-cancellable operating leases is set out below:
PARTICULARS
AS AT
31 MARCH 2015
AS AT
31 MARCH 2014
Not later than one year 384 359
Later than one year and not later than five years 1,259 1,007
Beyond five years 852 937
2,495 2,303
During the year ended 31 March 2014, the Company entered into a non-cancellable operating lease for an office and laboratory facility in the United
States of America. The future minimum rental payments in respect of this lease are ` 1,458 (USD 23 million) and ` 1,556 (USD 26 million) as at 31 March
2015 and 31 March 2014, respectively.
208